Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of cystatin C in urogenital malignancy

14 Dec 2022

Abstract excerpt

Urogenital malignancy accounts for one of the major causes of cancer-related deaths globally. Numerous studies have investigated novel molecular markers in the blood circulation, tumor tissue, or urine in order to assist in the clinical identification of tumors at early stages, predict the response of therapeutic strategies, and give accurate prognosis assessment. As an endogenous inhibitor of lysosomal cysteine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Kidney Disease and Diabetes
Share to Iron Metabolism and Disorders
Share to Protease and Inhibitor Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36589819
DOI: 10.3389/fendo.2022.1082871

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of cystatin C in urogenital malignancyPMID 36589819Read ↗

Urinary Biomarkers in Bladder Cancer: FDA-Approved Tests and Emerging Tools for Diagnosis and SurveillanceSemantic proximity Read ↗

Recent Advances in the Diagnosis and Management of Bladder Cancer.Semantic proximity Read ↗

Prevalence of bladder cancer in Costello syndrome: New insights to drive clinical decision-making.Semantic proximity Read ↗

Bladder Cancer: A Review.Semantic proximity Read ↗

Potential new urinary markers in the early detection of bladder cancerSemantic proximity Read ↗

Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular VesiclesSemantic proximity Read ↗

Improving diagnostic molecular tests to monitor urothelial carcinoma recurrence.Semantic proximity Read ↗

Proteomics as a Complementary Technique to Characterize Bladder CancerSemantic proximity Read ↗

Proteomics and genomics of urinary bladder cancer.Semantic proximity Read ↗

Emerging Roles of Urine-Derived Components for the Management of Bladder Cancer: One Man’s Trash is Another Man’s TreasureSemantic proximity Read ↗

Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies.Semantic proximity Read ↗

Molecular pathogenesis of urothelial carcinoma: the clinical utility of emerging new biomarkers and future molecular classification of bladder cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.